Literature DB >> 11511535

Regulation of cyclin D2 gene expression by the Myc/Max/Mad network: Myc-dependent TRRAP recruitment and histone acetylation at the cyclin D2 promoter.

C Bouchard1, O Dittrich, A Kiermaier, K Dohmann, A Menkel, M Eilers, B Lüscher.   

Abstract

Myc oncoproteins promote cell cycle progression in part through the transcriptional up-regulation of the cyclin D2 gene. We now show that Myc is bound to the cyclin D2 promoter in vivo. Binding of Myc induces cyclin D2 expression and histone acetylation at a single nucleosome in a MycBoxII/TRRAP-dependent manner. Down-regulation of cyclin D2 mRNA expression in differentiating HL60 cells is preceded by a switch of promoter occupancy from Myc/Max to Mad/Max complexes, loss of TRRAP binding, increased HDAC1 binding, and histone deacetylation. Thus, recruitment of TRRAP and regulation of histone acetylation are critical for transcriptional activation by Myc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11511535      PMCID: PMC312761          DOI: 10.1101/gad.907901

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  28 in total

1.  Transactivation-defective c-MycS retains the ability to regulate proliferation and apoptosis.

Authors:  Q Xiao; G Claassen; J Shi; S Adachi; J Sedivy; S R Hann
Journal:  Genes Dev       Date:  1998-12-15       Impact factor: 11.361

2.  The ATM-related cofactor Tra1 is a component of the purified SAGA complex.

Authors:  P A Grant; D Schieltz; M G Pray-Grant; J R Yates; J L Workman
Journal:  Mol Cell       Date:  1998-12       Impact factor: 17.970

3.  The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins.

Authors:  S B McMahon; H A Van Buskirk; K A Dugan; T D Copeland; M D Cole
Journal:  Cell       Date:  1998-08-07       Impact factor: 41.582

4.  Identification and characterization of specific DNA-binding complexes containing members of the Myc/Max/Mad network of transcriptional regulators.

Authors:  A Sommer; K Bousset; E Kremmer; M Austen; B Lüscher
Journal:  J Biol Chem       Date:  1998-03-20       Impact factor: 5.157

5.  Histone deacetylase activity is required for full transcriptional repression by mSin3A.

Authors:  C A Hassig; T C Fleischer; A N Billin; S L Schreiber; D E Ayer
Journal:  Cell       Date:  1997-05-02       Impact factor: 41.582

6.  The essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc.

Authors:  S B McMahon; M A Wood; M D Cole
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

7.  Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27.

Authors:  C Bouchard; K Thieke; A Maier; R Saffrich; J Hanley-Hyde; W Ansorge; S Reed; P Sicinski; J Bartek; M Eilers
Journal:  EMBO J       Date:  1999-10-01       Impact factor: 11.598

8.  Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression.

Authors:  C D Laherty; W M Yang; J M Sun; J R Davie; E Seto; R N Eisenman
Journal:  Cell       Date:  1997-05-02       Impact factor: 41.582

9.  Analysis of the DNA-binding activities of Myc/Max/Mad network complexes during induced differentiation of U-937 monoblasts and F9 teratocarcinoma cells.

Authors:  L G Larsson; F Bahram; H Burkhardt; B Lüscher
Journal:  Oncogene       Date:  1997-08-07       Impact factor: 9.867

10.  c-MYC interacts with INI1/hSNF5 and requires the SWI/SNF complex for transactivation function.

Authors:  S W Cheng; K P Davies; E Yung; R J Beltran; J Yu; G V Kalpana
Journal:  Nat Genet       Date:  1999-05       Impact factor: 38.330

View more
  135 in total

Review 1.  Histone acetylation: a switch between repressive and permissive chromatin. Second in review series on chromatin dynamics.

Authors:  Anton Eberharter; Peter B Becker
Journal:  EMBO Rep       Date:  2002-03       Impact factor: 8.807

2.  Dynamics of global histone acetylation and deacetylation in vivo: rapid restoration of normal histone acetylation status upon removal of activators and repressors.

Authors:  Yael Katan-Khaykovich; Kevin Struhl
Journal:  Genes Dev       Date:  2002-03-15       Impact factor: 11.361

Review 3.  Disentangling the MYC web.

Authors:  David Levens
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-30       Impact factor: 11.205

4.  BAF53 forms distinct nuclear complexes and functions as a critical c-Myc-interacting nuclear cofactor for oncogenic transformation.

Authors:  Jeonghyeon Park; Marcelo A Wood; Michael D Cole
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

5.  Post-TATA binding protein recruitment clearance of Gcn5-dependent histone acetylation within promoter nucleosomes.

Authors:  Irini Topalidou; Manolis Papamichos-Chronakis; George Thireos
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

6.  MYC recruits the TIP60 histone acetyltransferase complex to chromatin.

Authors:  Scott R Frank; Tiziana Parisi; Stefan Taubert; Paula Fernandez; Miriam Fuchs; Ho-Man Chan; David M Livingston; Bruno Amati
Journal:  EMBO Rep       Date:  2003-06       Impact factor: 8.807

7.  Visualization of Myc/Max/Mad family dimers and the competition for dimerization in living cells.

Authors:  Asya V Grinberg; Chang-Deng Hu; Tom K Kerppola
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

8.  Myc-induced proliferation and transformation require Akt-mediated phosphorylation of FoxO proteins.

Authors:  Caroline Bouchard; Judith Marquardt; Alexandra Brás; René H Medema; Martin Eilers
Journal:  EMBO J       Date:  2004-07-08       Impact factor: 11.598

9.  The c-MYC oncoprotein is a substrate of the acetyltransferases hGCN5/PCAF and TIP60.

Authors:  Jagruti H Patel; Yanping Du; Penny G Ard; Charles Phillips; Beth Carella; Chi-Ju Chen; Carrie Rakowski; Chandrima Chatterjee; Paul M Lieberman; William S Lane; Gerd A Blobel; Steven B McMahon
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

Review 10.  MYC, Metabolism, and Cancer.

Authors:  Zachary E Stine; Zandra E Walton; Brian J Altman; Annie L Hsieh; Chi V Dang
Journal:  Cancer Discov       Date:  2015-09-17       Impact factor: 39.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.